Saliva test for head and neck cancer? new study explores microRNA clues

NCT ID NCT04305366

Ongoing Knowledge-focused Sponsor: University of Colorado, Denver Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study collects saliva, blood, and tissue samples from 225 people with and without head and neck cancer. Researchers look for tiny genetic markers called microRNAs that might help diagnose the disease or predict how it will progress. The goal is to develop a simple, non-invasive test to improve detection and monitoring.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a simple saliva or blood test to detect head and neck cancer earlier or monitor its return.
What could go wrong: This is an observational study collecting samples, not testing a treatment. It is still early, and the markers may not prove reliable enough for routine use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SQUAMOUS CELL CARCINOMA OF HEAD AND NECK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

head and neck squamous cell carcinoma Squamous Cell Carcinoma of Head and Neck

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SQUAMOUS CELL CARCINOMA OF HEAD AND NECK

Contacts and locations

Locations

University of Colorado Cancer Center

Aurora, Colorado, 80045, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.